The CorEvitas RA Registry is the largest RA real world prospective cohort study in the world. We collect data from both physicians and patients at the time of a clinical encounter and longitudinally thereafter.
432,027
STUDY VISITS
56,090
PATIENTS
857
RHEUMATOLOGISTS
Participating Sites
CorEvitas has clinical sites across the U.S. and we are always interested in expanding the registry for qualified sites.
Clinical outcome measures and PROs in the CorEvitas RA Registry.
Among the variables we collect, some of the key outcome measures to inform your research include:
Calculated Outcomes
- Disease Activity Score (DAS28)
- Clinical Disease Activity Index (CDAI)
- Simple Disease Activity Index (SDAI)
Patient Reported Outcomes
- Euro-QoL Group EQ-5D-3L
- Health Assessment Questionnaire (HAQ)
- Patient Global Assessment
- Pain Visual Analogue Scale
- Morning Stiffness Visual Analogue Scale
- Fatigue Visual Analogue Scale
Our Publications